S&P 500   4,238.25 (-1.17%)
DOW   33,108.82 (-0.97%)
QQQ   356.34 (-1.36%)
AAPL   171.21 (-1.46%)
MSFT   316.04 (-1.79%)
META   302.12 (-1.53%)
GOOGL   132.72 (-1.08%)
AMZN   125.94 (-2.72%)
TSLA   247.94 (-1.45%)
NVDA   444.31 (-0.78%)
NIO   8.65 (-1.59%)
BABA   84.29 (-2.59%)
AMD   102.15 (-1.08%)
T   14.74 (+0.48%)
F   12.12 (-1.54%)
MU   68.39 (+0.63%)
CGC   0.70 (-5.56%)
GE   108.53 (-0.24%)
DIS   80.62 (-1.29%)
AMC   7.97 (-2.21%)
PFE   33.86 (-0.24%)
PYPL   57.80 (-1.30%)
NFLX   381.52 (+0.31%)
S&P 500   4,238.25 (-1.17%)
DOW   33,108.82 (-0.97%)
QQQ   356.34 (-1.36%)
AAPL   171.21 (-1.46%)
MSFT   316.04 (-1.79%)
META   302.12 (-1.53%)
GOOGL   132.72 (-1.08%)
AMZN   125.94 (-2.72%)
TSLA   247.94 (-1.45%)
NVDA   444.31 (-0.78%)
NIO   8.65 (-1.59%)
BABA   84.29 (-2.59%)
AMD   102.15 (-1.08%)
T   14.74 (+0.48%)
F   12.12 (-1.54%)
MU   68.39 (+0.63%)
CGC   0.70 (-5.56%)
GE   108.53 (-0.24%)
DIS   80.62 (-1.29%)
AMC   7.97 (-2.21%)
PFE   33.86 (-0.24%)
PYPL   57.80 (-1.30%)
NFLX   381.52 (+0.31%)
S&P 500   4,238.25 (-1.17%)
DOW   33,108.82 (-0.97%)
QQQ   356.34 (-1.36%)
AAPL   171.21 (-1.46%)
MSFT   316.04 (-1.79%)
META   302.12 (-1.53%)
GOOGL   132.72 (-1.08%)
AMZN   125.94 (-2.72%)
TSLA   247.94 (-1.45%)
NVDA   444.31 (-0.78%)
NIO   8.65 (-1.59%)
BABA   84.29 (-2.59%)
AMD   102.15 (-1.08%)
T   14.74 (+0.48%)
F   12.12 (-1.54%)
MU   68.39 (+0.63%)
CGC   0.70 (-5.56%)
GE   108.53 (-0.24%)
DIS   80.62 (-1.29%)
AMC   7.97 (-2.21%)
PFE   33.86 (-0.24%)
PYPL   57.80 (-1.30%)
NFLX   381.52 (+0.31%)
S&P 500   4,238.25 (-1.17%)
DOW   33,108.82 (-0.97%)
QQQ   356.34 (-1.36%)
AAPL   171.21 (-1.46%)
MSFT   316.04 (-1.79%)
META   302.12 (-1.53%)
GOOGL   132.72 (-1.08%)
AMZN   125.94 (-2.72%)
TSLA   247.94 (-1.45%)
NVDA   444.31 (-0.78%)
NIO   8.65 (-1.59%)
BABA   84.29 (-2.59%)
AMD   102.15 (-1.08%)
T   14.74 (+0.48%)
F   12.12 (-1.54%)
MU   68.39 (+0.63%)
CGC   0.70 (-5.56%)
GE   108.53 (-0.24%)
DIS   80.62 (-1.29%)
AMC   7.97 (-2.21%)
PFE   33.86 (-0.24%)
PYPL   57.80 (-1.30%)
NFLX   381.52 (+0.31%)
OTCMKTS:CLXPF

Cybin (CLXPF) Stock Forecast, Price & News

$0.57
+0.04 (+7.55%)
(As of 10/2/2023 ET)
Compare
Today's Range
$0.52
$0.60
50-Day Range
$0.30
$0.63
52-Week Range
$0.49
$3.38
Volume
5.72 million shs
Average Volume
551,962 shs
Market Capitalization
$84.70 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

CLXPF stock logo

About Cybin (OTCMKTS:CLXPF) Stock

Cybin Inc., a life sciences company, focuses on developing psychedelic therapeutics to treat various psychiatric and neurological conditions. The company operates through two segments, Serenity Life and Natures Journey. The Serenity Life segment engages in the research and development of pharmaceutical and nutraceutical psilocybin products. The Natures Journey segment focuses on non-psychedelic medical mushroom nutraceutical products. The company offers its products through various form factors, such as capsules, powders, and effervescent tablets. Cybin Inc. is headquartered in Toronto, Canada.

CLXPF Price History

CLXPF Stock News Headlines

Is Gold Really Boring?
Many investors perceive gold as a "boring" investment. But according to MoneyWeek, that's a good thing. Gold helps investors sleep soundly as it preserves wealth and creates a hedge against inflation. Today, there's a unique way to invest in gold, with real advantages over coins and mining stocks.
The "Plug and Play" Model Putting Online Giants to Shame
While e-commerce has been undergoing a turbulent time, a "simple" model has grown 4X faster than Amazon over the last 3 years. Applying this model to high-margin, recession-resistant businesses has shown to be profitable. But that's just the beginning of explaining the 400+% growth - and potential - of this "diamond in the rough."
See More Headlines
Receive CLXPF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cybin and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Holding & Other Investment Offices
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:CLXPF
CIK
N/A
Fax
N/A
Employees
6
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$680,000.00
Book Value
$0.44 per share

Miscellaneous

Free Float
N/A
Market Cap
$84.70 million
Optionable
Not Optionable
Beta
N/A
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

  • Mr. Eric So L.L.B. (Age 45)
    LLB, Co-Founder, Pres & Exec. Chairman
  • Mr. Douglas L. Drysdale (Age 51)
    Chief Exec. Officer
  • Mr. Paul Glavine (Age 31)
    Co-Founder, Chief Growth Officer & Director
  • Mr. John Kanakis (Age 40)
    Co-Founder & Chief Bus. Officer
  • Mr. Greg Cavers (Age 50)
    Chief Financial Officer
  • Dr. Alex L. Nivorozhkin Ph.D. (Age 61)
    Chief Scientific Officer
  • Mr. Gabriel Fahel (Age 45)
    Chief Legal Officer
  • Sara Brittany Somerset
    Chief Communications Officers
  • Lori Challenger
    Chief of Staff
  • James Andrews
    Chief Cultivation & Extraction Officer













CLXPF Stock - Frequently Asked Questions

How have CLXPF shares performed in 2023?

Cybin's stock was trading at $0.2971 at the beginning of the year. Since then, CLXPF stock has increased by 91.9% and is now trading at $0.57.
View the best growth stocks for 2023 here
.

What is Cybin's stock symbol?

Cybin trades on the OTCMKTS under the ticker symbol "CLXPF."

How do I buy shares of Cybin?

Shares of CLXPF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Cybin's stock price today?

One share of CLXPF stock can currently be purchased for approximately $0.57.

How much money does Cybin make?

Cybin (OTCMKTS:CLXPF) has a market capitalization of $84.70 million and generates $680,000.00 in revenue each year. The company earns $-24,420,000.00 in net income (profit) each year or ($0.24) on an earnings per share basis.

How can I contact Cybin?

The official website for the company is www.cybin.com. The company can be reached via phone at 416 567 4675 or via email at ir@cybin.com.

This page (OTCMKTS:CLXPF) was last updated on 10/3/2023 by MarketBeat.com Staff

My Account -